Regenerative Medicine & Patient Optimization
AHIRF has played a leading role in advancing regenerative medicine and patient optimization strategies across a wide range of hip conditions. This section highlights AHIRF's innovative research into biologic therapies, cartilage restoration, and tissue regeneration techniques aimed at preserving joint health and enhancing repair. By integrating cutting-edge regenerative treatments with comprehensive care pathways, AHIRF continues to push the boundaries of hip preservation and recovery for diverse patient populations.
Read Our Research on Regenerative Medicine & Patient Optimization
- Perioperative Testosterone Supplementation Improves Outcomes of Orthopaedic Surgeries: A Systematic Review of Heterogeneous Studies
- Orthobiologics as an Adjunct in Treatment of Femoroacetabular Impingement Syndrome: Cell-Based Therapies Facilitate Improved Postoperative Outcomes in the Setting of Acetabular Chondral Lesions – A Systematic Review
- Platelet-Rich Plasma Versus Surgery for the Management of Recalcitrant Greater Trochanteric Pain Syndrome: A Systematic Review
- Hip-Spine Syndrome: The Diagnostic Utility of Guided Intra-articular Hip Injections
- Editorial Commentary: Platelet-Rich Fibrin Matrix — Is This Stuff for Real?!
- Symposium: Evidence for the Use of Intra-articular Cortisone or Hyaluronic Acid Injection in the Hip
- Clinical Results of Hip Arthroscopy for Labral Tears: Comparison of Intraoperative Platelet-Rich Plasma (PRP) vs Bupivacaine Injection